Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 2 | BMC Cancer

Fig. 2

From: TRPM7 overexpression enhances the cancer stem cell-like and metastatic phenotypes of lung cancer through modulation of the Hsp90α/uPA/MMP2 signaling pathway

Fig. 2

TRPM7 is an independent indicator of poor prognosis in lung cancer. a Relative mRNA expression of TRPM7 in lung large cell carcinoma, adenocarcinoma, squamous cell carcinoma and adjacent normal tissues in GSE19188 dataset, n = 156. b Kaplan-Meier analysis of TRPM7 gene expression in Sir Run Run Shaw hospital lung cancer cohort. Patients with low TRPM7 expression had longer cumulative survival than those with high TRPM7 expression. c Photo images and (d) graphical representation of the differential expression of TRPM7 in Stage I, II, III and IV lung cancers. * p < 0.05, ** p < 0.01, *** p < 0.001

Back to article page